Evidence map›Paper›PMID 30850631›Full record

ArticleScientific reports2019

Cytotoxicity profiling of deep eutectic solvents to human skin cells.

I P E Macário, H Oliveira, A C Menezes, S P M Ventura, J L Pereira, A M M Gonçalves, J A P Coutinho, F J M Gonçalves

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. The Versatility of NADES Across Applications.Molecules (Basel, Switzerland) · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

I P E MacárioDepartment of Biology & CESAM, University of Aveiro, 3810-193, Aveiro, Portugal.
H OliveiraDepartment of Biology & CESAM, University of Aveiro, 3810-193, Aveiro, Portugal. holiveira@ua.pt.ORCID 0000-0002-4673-0696
A C MenezesDepartment of Biology & CESAM, University of Aveiro, 3810-193, Aveiro, Portugal.ORCID 0000-0002-3386-1910
S P M VenturaCICECO - Aveiro Institute of Materials & Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal.
J L PereiraDepartment of Biology & CESAM, University of Aveiro, 3810-193, Aveiro, Portugal.ORCID 0000-0001-7573-6184
A M M GonçalvesDepartment of Biology & CESAM, University of Aveiro, 3810-193, Aveiro, Portugal.
J A P CoutinhoCICECO - Aveiro Institute of Materials & Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal.
F J M GonçalvesDepartment of Biology & CESAM, University of Aveiro, 3810-193, Aveiro, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tailor-made character of deep eutectic solvents (DES) turns them very attractive to be used in several applications, including in health-related areas such as pharmaceutical, nutraceutical, and cosmetic industries. However, although DES has been touted as "green" solvents, several works proved that their potential toxicity should not be neglected. Using the premise of DES applicability in the cosmetic and pharmaceutical sectors, we chose two cell lines to work as a skin model (keratinocytes HaCaT and tumor melanocytes MNT-1), to assess DES cytotoxicity. The effect of three different hydrogen bond acceptors (HBA) ([Chol]Cl, [N

Indexed as

Cell LineCell Line, TumorCell SurvivalGreen Chemistry TechnologyHumansHydrogen BondingKeratinocytesMaterials TestingMelanocytesMelanomaSkinSolventsSolvents

Identifiers

PMID30850631
PMCPMC6408470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.